Verastem reported $46.69M in Cash and Equivalent for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Cash And Equivalent Change
AstraZeneca AZN:LN 6329M 738M
Cytokinetics CYTK:US $ 115.42M 2.76M
Immunogen IMGN:US $ 437.66M 41.09M
Novartis NOVN:VX SF 12407M 5196M
Tg Therapeutics TGTX:US $ 298.89M 27.62M
Verastem VSTM:US $ 46.69M 22.37M
Ziopharm Oncology ZIOP:US $ 68.26M 7.8M